OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2025
(2)
2022
(2)
2015
(2)
2026
(1)
2024
(1)
2023
(1)
2019
(1)
2018
(1)
2014
(1)
2013
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.
Not available
S-EPMC3295561
|
biostudies-literature
Cite
Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Not available
S-EPMC5569674
|
biostudies-literature
Cite
Cross-Cultural Adaptation and Validation of the Perception of the Doctor-Patient Relationship (PREMEPA) Questionnaire in Chronic Multi-Pathological Patients.
Not available
S-EPMC10981856
|
biostudies-literature
Cite
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials.
Not available
S-EPMC5815402
|
biostudies-literature
Cite
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.
Not available
S-EPMC4397279
|
biostudies-literature
Cite
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.
Not available
S-EPMC4881370
|
biostudies-literature
Cite
Perceptions, Beliefs, and Knowledge of Oral and Familial Cancer in an Indigenous Community of Chile: A Mixed Quantitative-Qualitative Study.
Not available
S-EPMC12412389
|
biostudies-literature
Cite
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
Not available
S-EPMC4226804
|
biostudies-literature
Cite
Effectiveness of Synchronous Telerehabilitation Versus Face-to-Face Physical Therapy in Older Adults Who Are Frail: Protocol for a Randomized Controlled Trial.
Not available
S-EPMC12485262
|
biostudies-literature
Cite
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation.
Not available
S-EPMC9511784
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets